Bradykinin B1 receptor antagonists as potential therapeutic agents for pain.
Huang
Hui
H
Johnson & Johnson Pharmaceutical Research and Development, Spring House, Pennsylvania 19477-0776, USA.
Player
Mark R
MR
D000577:Amides / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D000700:Analgesics / Q000737:chemistry* / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D065169:Bradykinin B1 Receptor Antagonists; D002986:Clinical Trials as Topic; D004353:Drug Evaluation, Preclinical; D006801:Humans; D008958:Models, Molecular; D010146:Pain / Q000188:drug therapy*; D043783:Receptor, Bradykinin B1 / Q000502:physiology; D013449:Sulfonamides / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use
D000577:Amides; D000700:Analgesics; D065169:Bradykinin B1 Receptor Antagonists; D043783:Receptor, Bradykinin B1; D013449:Sulfonamides